| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/25/2013 | US20130102602 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions |
| 04/25/2013 | US20130102590 Pyridopyrimidinone inhibitors of kinases |
| 04/25/2013 | US20130102574 2-methylene-vitamin d analogs and their uses |
| 04/25/2013 | US20130102573 2-methylene-vitamin d analogs and their uses |
| 04/25/2013 | US20130102567 3-Desoxy-2-Methylene-Vitamin D Analogs and Their Uses |
| 04/25/2013 | US20130102545 Temperature dependent activation of catalytic nucleic acids for controlled active substance release |
| 04/25/2013 | US20130102482 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
| 04/25/2013 | US20130101666 Liposome including elastin-like polypeptide conjugated to moiety containing hydrophobic group, chemosensitizer and anticancer agent and use thereof |
| 04/25/2013 | US20130101644 Tocotrienol compositions |
| 04/25/2013 | US20130101632 Nanoparticulate formulations of mithramycin or mithramycin analogues for treating cancer |
| 04/25/2013 | US20130101627 Composition with extracts from olive leaf, yarrow and rosemary for treating human diseases and conditions |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | US20130101577 Extended Soluble PH20 Polypeptides and uses thereof |
| 04/25/2013 | US20130101557 Recombinant Adenovirus Having Anti-Angiogenesis Activity |
| 04/25/2013 | US20130098357 Cerivastatin to treat pulmonary disorders |
| 04/25/2013 | CA2852967A1 Antigen presenting cancer vaccine |
| 04/25/2013 | CA2852960A1 Antigen presenting cancer vaccine with gamma interferon |
| 04/25/2013 | CA2852917A1 Amine cationic lipids and uses thereof |
| 04/25/2013 | CA2852914A1 Meldrum 's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors |
| 04/25/2013 | CA2852777A1 Lyophilized liposomes |
| 04/25/2013 | CA2852682A1 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer |
| 04/25/2013 | CA2852622A1 Acid addition salts of 5.alpha.-hydroxy-6.beta.-[2-(1h-imidazol-4-yl)ethylamino]cholestan-3.beta.-ol |
| 04/25/2013 | CA2852607A1 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones |
| 04/25/2013 | CA2852594A1 Peptide compounds derived from melanotransferrin and uses thereof |
| 04/25/2013 | CA2852518A1 Method for inhibition of deubiquitinating activity |
| 04/25/2013 | CA2852274A1 Therapeutic combination for the treatment of cancer |
| 04/25/2013 | CA2851808A1 Use of inhibitors of bruton's tyrosine kinase (btk) |
| 04/25/2013 | CA2851795A1 Anti-cd22 chimeric antigen receptors |
| 04/25/2013 | CA2851144A1 Novel plant defensins and use in the treatment of proliferative diseases |
| 04/25/2013 | CA2850987A1 Substituted biaryl alkyl amides |
| 04/25/2013 | CA2850245A1 Pd-l1 based immunotherapy |
| 04/25/2013 | CA2849564A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | CA2838646A1 Conveniently injectable or implantable sustained-release antioxidant formulations for therapies of ocular maladies or cancer |
| 04/24/2013 | EP2584043A2 Anti-glypican 3 antibody having improved kinetics in plasma |
| 04/24/2013 | EP2583976A2 Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens |
| 04/24/2013 | EP2583966A2 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases |
| 04/24/2013 | EP2583692A1 Inhibitor of expression of dominant allele |
| 04/24/2013 | EP2583686A1 Agent for reducing acetaldehyde in oral cavity |
| 04/24/2013 | EP2583678A2 Small molecule immunopotentiators and assays for their detection |
| 04/24/2013 | EP2582729A1 Anti-axl antibodies and methods of use |
| 04/24/2013 | EP2582725A2 Anti-dr4 agonist antibodies |
| 04/24/2013 | EP2582715A2 Growth hormone secretatogue receptor antagonists and uses thereof |
| 04/24/2013 | EP2582699A1 Substituted triazolopyridines |
| 04/24/2013 | EP2582689A1 New polymorphic form of imatinib base and preparation of salts thereof |
| 04/24/2013 | EP2582393A1 Dose selection of adjuvanted synthetic nanocarriers |
| 04/24/2013 | EP2582390A1 Immunotherapeutic method involving cd123 (il-3r ) antibodies and immunostimulating complex |
| 04/24/2013 | EP2582388A2 Detection of epha3 as a marker of the presence of a solid tumor |
| 04/24/2013 | EP2582384A2 Compositions and methods for treating cancer |
| 04/24/2013 | EP2582371A1 Methods of treating or preventing estrogen-related diseases |
| 04/24/2013 | EP2582369A1 An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative |
| 04/24/2013 | CN202892459U Novel antineoplastic pills |
| 04/24/2013 | CN1758923B Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria |
| 04/24/2013 | CN1653050B Opioid and opioid-like compounds and uses thereof |
| 04/24/2013 | CN1552734B Recombination glant associated virus carrier induced TNF concerned cytonecrosis ligand peptide fragment and its use |
| 04/24/2013 | CN1520303B Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 04/24/2013 | CN103068849A Anti-bv8 antibodies and uses thereof |
| 04/24/2013 | CN103068836A 癌症疫苗 Cancer vaccine |
| 04/24/2013 | CN103068824A Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases |
| 04/24/2013 | CN103068803A Imidazo[4,5-c]quinolines as DNA-PK inhibitors |
| 04/24/2013 | CN103068405A Targeted pyrrolobenzodiazapine conjugates |
| 04/24/2013 | CN103068404A Pharmaceutical multimeric particles, and manufacturing method for same |
| 04/24/2013 | CN103068403A Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom |
| 04/24/2013 | CN103068395A Therapeutic agent for disease |
| 04/24/2013 | CN103068393A Methods and compositions for inhibition of the transitional endoplasmic reticulum atpase |
| 04/24/2013 | CN103068391A Morpholino pyrimidines and their use in therapy |
| 04/24/2013 | CN103068386A Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictor |
| 04/24/2013 | CN103068384A Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites |
| 04/24/2013 | CN103068381A Medicinal agent for prevention and/or treatment of hepatocellular carcinoma |
| 04/24/2013 | CN103060331A Preparation method and application of capsid-protein-mutant double-stranded recombinant adeno-associated virus containing mediated-membrane-stabile CD40L gene |
| 04/24/2013 | CN103060323A Antisenseoligonuclleotide and application of antisenseoligonuclleotide in preparation of medicament for treating gastric cancer |
| 04/24/2013 | CN103060316A Preparation method and application of target human nucleolar protein hRrp15esiRNA |
| 04/24/2013 | CN103060299A L-asparaginase variant with increased activity |
| 04/24/2013 | CN103059297A Multifunctional degradable polyasparaginate modified polymer and preparation method thereof |
| 04/24/2013 | CN103059295A Hydrophobic-modified polyethyleneimine and application thereof as protein carrier |
| 04/24/2013 | CN103059289A Polyethylene glycol modified D-glucosamine, and synthesis and application thereof |
| 04/24/2013 | CN103059184A Amino porphyrin- poly (N-isopropylacrylamide) europium coordination compound and preparation method thereof |
| 04/24/2013 | CN103059165A Polysaccharide acylate and preparation method thereof |
| 04/24/2013 | CN103059160A Beta-glucan GFPBW1, its preparation method and application |
| 04/24/2013 | CN103059138A Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| 04/24/2013 | CN103059137A Preparation and application of human interleukin-6 receptor (hIL6R)-resistant antibody with high affinity |
| 04/24/2013 | CN103059112A Method of extracting anti-intestinal cancer active protein from nostoc commune |
| 04/24/2013 | CN103059104A Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 04/24/2013 | CN103059030A Pyrimidine compound with effect of adhesion kinase inhibition and preparation method and application thereof |
| 04/24/2013 | CN103059019A Imidazole [4,5-c] pyridine-7-methanamide derivative as well as preparation method and medical application thereof |
| 04/24/2013 | CN103059016A Coptisine derivatives as well as synthesis methods and medicinal application thereof to resistance of tumors |
| 04/24/2013 | CN103059013A New crystal of Dasatinib monohydrate and preparation method thereof |
| 04/24/2013 | CN103059005A Chrysin amide derivative and medical application thereof |
| 04/24/2013 | CN103059002A Pyrimidine derivative with Aurora kinase inhibitory activity and preparation method and application thereof |
| 04/24/2013 | CN103059001A Quinazolinone Schiff base containing triazole and preparation method thereof |
| 04/24/2013 | CN103058995A Quinazolinyl piperazine derivative and purpose thereof |
| 04/24/2013 | CN103058974A Natural compound and preparation method and application thereof |
| 04/24/2013 | CN103058971A Benzoquinone spiro compound derived from aspergillus aculeatus and application of benzoquinone spiro compound |
| 04/24/2013 | CN103058959A N-(2-(4-methylpiperazine-1-yl)-5-formylphenyl) amide compound and application thereof |
| 04/24/2013 | CN103058949A Thiazole derivative acting as DHODH inhibitor and its application |
| 04/24/2013 | CN103058938A 4-aniline quinazoline compound substituting cinnamic acid, and preparation method and application thereof |
| 04/24/2013 | CN103058935A Pyrimidine compound as well as preparation method and use for same |
| 04/24/2013 | CN103058927A Quinoline and application thereof |
| 04/24/2013 | CN103058922A Crystal form of aromatic urea for antitumor drug and preparation method of crystal form |
| 04/24/2013 | CN103058846A Benzoquinone derivative from aspergillus aculeatus and application of benzoquinone derivative |
| 04/24/2013 | CN103058832A Application of selective estrogen receptor modulator |